Mirko Stange

Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA.

Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.

Part of Thermo Fisher Scientific, Inc., Konelab Oy manufactures clinical chemistry analyzers and modular laboratory automation systems.

Part of Thermo Fisher Scientific, Inc., Difco Laboratories, Inc. produces products to help detect bacterial contamination in food and drugs. The company is based in Detroit, MI. The company was founded by Ian P. Thrippleton. Difco Laboratories was acquired by Becton, Dickinson & Co. on July 02, 1997.

Rados Technology Oy develops and markets equipment and systems for detecting and measuring of ionising radiation, radioactive contamination and nuclear waste. Its equipment is used for personnel dosimeter, environmental radiation monitoring, and nuclear waste clearance. The company was established in 1992 and is headquartered in Turku, Finland.

Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001.

Part of SnowWorld NV, Seapro Diagnostics Ltd. is a British company that manufactures and markets biopharmaceuticals and related products. The company is based in Liverpool, UK. Seapro Diagnostics was acquired by Fornix BioSciences NV on October 29, 2003.

Labmaster Oy manufactures and distributes diagnostic tools for applications in functional food research and routine clinical diagnostics. The company was founded in 1986 and is headquartered in Turku, Finland.

Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom.

Fluilogic Oy develops and produces micro and nanoliter dispensing modules for applications which are used in precise liquid handling in global markets. The company was founded in 1979 and is headquartered in Espoo, Finland.

Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002.

MERLIN Diagnostika GmbH operates as a microbiological diagnostics company, manufactures and supplies diagnostic equipment to identify bacteria and yeasts. Its products include MICRONAUT-E, which identifies enterobacteriaceae and other gramnegative bacteria; MICRONAUT-NF that identifies non-fermenting and gram-negative bacteria; MICRONAUT-IDS, which identifies gram-positive and gram-negative bacteria; MICRONAUT-RPO that identifies gram-positive bacteria; and MICRONAUT-Candida, which identifies clinically relevant yeasts. The company was founded in 1990 and is headquartered in Bornheim-Hersel, Germany.

RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country.

Part of ValiRx Plc, ValiRx Finland Oy provides medical and clinical services, and distributes pharmaceutical drug preparations. The company is based in Oulu, Finland. ValiRx Finland was acquired by ValiRx Plc on August 18, 2011.

IXRF Systems, Inc. designs and manufactures software and hardware for the micro-analysis and x-ray fluorescence industries. Its products include micro-XRF, mobile -XRF, vacuum devices, stages, upgrades, sdd detectors. The company was founded in 1993 and is headquartered in Austin, TX.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Part of Med Group Oy, Med Group Holding Oy functions as an investment holding Finnish company. The company is based in Vantaa, Finland.

Klinik Healthcare Solutions Oy operates a health website that helps consumers to identify their health issues, gives guidance about treatment, and connects to health specialists. It also offers a marketing platform for health products, devices, over-the-counter medications, and health professionals. The company was founded by Hannu Sakari Nissinen and Petteri Matias Hirvonen on March 1, 2013 and is headquartered in Helsinki, Finland.

Julz Co LLC (Julz) is a venture capital firm founded in 2016. The firm is headquartered in Chapel Hill, North Carolina.

Good Therapeutics, Inc. operates as a biotechnology company. It develops "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. The company was founded by John Mulligan in 2016 and is headquartered in Seattle, WA.

VideoVisit Oy engages in the provision of digital telehealth solutions. It offers remote care platform that offers all necessary tools for social and healthcare service providers to deliver care beyond hospital walls including VideoVisit HOME, VideoVisit LIVE, and VideoVisit REMOTE. The company was founded by Esa Ojala and Juhana Ojala in 2010 and is headquartered in Finland.

Bluejay Mobile Health, Inc. is a full-service medical mobile technology and telehealth company. The company is headquartered in Livermore, CA.

GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.

Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation.

Qbiotix Ltd. develops medical diagnostic technology. The company is based in Ledbury, UK.